200 related articles for article (PubMed ID: 25343480)
1. Polyclonal T-cells express CD1a in Langerhans cell histiocytosis (LCH) lesions.
West JA; Olsen SL; Mitchell JM; Priddle RE; Luke JM; Akefeldt SO; Henter JI; Turville C; Kannourakis G
PLoS One; 2014; 9(10):e109586. PubMed ID: 25343480
[TBL] [Abstract][Full Text] [Related]
2. Does CD1a Expression Influence T Cell Function in Patients With Langerhans Cell Histiocytosis?
Mitchell J; Kannourakis G
Front Immunol; 2021; 12():773598. PubMed ID: 34956202
[TBL] [Abstract][Full Text] [Related]
3. Detection of clonal histiocytes in Langerhans cell histiocytosis: biology and clinical significance.
Willman CL
Br J Cancer Suppl; 1994 Sep; 23():S29-33. PubMed ID: 7521201
[TBL] [Abstract][Full Text] [Related]
4. Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.
Peters TL; McClain KL; Allen CE
Mol Ther; 2011 Aug; 19(8):1433-9. PubMed ID: 21654633
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
[TBL] [Abstract][Full Text] [Related]
6. Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease.
da Costa CE; Egeler RM; Hoogeboom M; Szuhai K; Forsyth RG; Niesters M; de Krijger RR; Tazi A; Hogendoorn PC; Annels NE
J Pathol; 2007 Jun; 212(2):188-97. PubMed ID: 17447723
[TBL] [Abstract][Full Text] [Related]
7. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow involvement of Langerhans cell histiocytosis: immunohistochemical evaluation of bone marrow for CD1a, Langerin, and S100 expression.
Kim HK; Park CJ; Jang S; Cho YU; Park SH; Koh KN; Im HJ; Seo JJ
Histopathology; 2014 Dec; 65(6):742-8. PubMed ID: 25138018
[TBL] [Abstract][Full Text] [Related]
9. Telomere length shortening in Langerhans cell histiocytosis.
Bechan GI; Meeker AK; De Marzo AM; Racke F; Jaffe R; Sugar E; Arceci RJ
Br J Haematol; 2008 Feb; 140(4):420-8. PubMed ID: 18162125
[TBL] [Abstract][Full Text] [Related]
10. No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies.
da Costa CE; Szuhai K; van Eijk R; Hoogeboom M; Sciot R; Mertens F; Björgvinsdóttir H; Debiec-Rychter M; de Krijger RR; Hogendoorn PC; Egeler RM; Annels NE
Genes Chromosomes Cancer; 2009 Mar; 48(3):239-49. PubMed ID: 19051326
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis.
Rust R; Kluiver J; Visser L; Harms G; Blokzijl T; Kamps W; Poppema S; van den Berg A
J Pathol; 2006 Aug; 209(4):474-83. PubMed ID: 16718746
[TBL] [Abstract][Full Text] [Related]
12. Prominent Langerhans' cell migration in the arthropod bite reactions simulating Langerhans' cell histiocytosis.
Kim SH; Kim DH; Lee KG
J Cutan Pathol; 2007 Dec; 34(12):899-902. PubMed ID: 18001411
[TBL] [Abstract][Full Text] [Related]
13. Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells.
Lim KPH; Milne P; Poidinger M; Duan K; Lin H; McGovern N; Abhyankar H; Zinn D; Burke TM; Eckstein OS; Chakraborty R; Sengal A; Scull B; Newell E; Merad M; McClain KL; Man TK; Ginhoux F; Collin M; Allen CE
Blood Adv; 2020 Jan; 4(1):87-99. PubMed ID: 31899802
[TBL] [Abstract][Full Text] [Related]
14. CD1a Reactivity in Non-neoplastic Adenohypophysis.
Pisapia DJ; Rosenblum MK; Lavi E
Am J Surg Pathol; 2016 Jun; 40(6):812-7. PubMed ID: 26999501
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow assessment in Langerhans cell histiocytosis.
Minkov M; Pötschger U; Grois N; Gadner H; Dworzak MN
Pediatr Blood Cancer; 2007 Oct; 49(5):694-8. PubMed ID: 17455318
[TBL] [Abstract][Full Text] [Related]
16. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
Egeler RM; Favara BE; van Meurs M; Laman JD; Claassen E
Blood; 1999 Dec; 94(12):4195-201. PubMed ID: 10590064
[TBL] [Abstract][Full Text] [Related]
17. Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report.
Lee JS; Ko GH; Kim HC; Jang IS; Jeon KN; Lee JH
J Korean Med Sci; 2006 Jun; 21(3):577-80. PubMed ID: 16778410
[TBL] [Abstract][Full Text] [Related]
18. Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions.
Egeler RM; Favara BE; Laman JD; Claassen E
Eur J Cancer; 2000 Oct; 36(16):2105-10. PubMed ID: 11044648
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
Milne P; Bigley V; Bacon CM; Néel A; McGovern N; Bomken S; Haniffa M; Diamond EL; Durham BH; Visser J; Hunt D; Gunawardena H; Macheta M; McClain KL; Allen C; Abdel-Wahab O; Collin M
Blood; 2017 Jul; 130(2):167-175. PubMed ID: 28512190
[TBL] [Abstract][Full Text] [Related]
20. Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis.
Makras P; Salagianni M; Revelos K; Anastasilakis AD; Schini M; Tsoli M; Kaltsas G; Andreakos E
J Clin Endocrinol Metab; 2015 Feb; 100(2):E282-6. PubMed ID: 25375981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
